Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients

BACKGROUND: Mutated circulating cell-free DNA (cfDNA) has been suggested as a surrogate marker of tumour burden and aggressiveness of disease. We examined the association between the level of plasma mutant cfDNA and metabolic tumour burden (MTB) measured by (18)F-fluoro-D-glucose positron emission t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Winther-Larsen, Anne, Demuth, Christina, Fledelius, Joan, Madsen, Anne Tranberg, Hjorthaug, Karin, Meldgaard, Peter, Sorensen, Boe Sandahl
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572172/
https://ncbi.nlm.nih.gov/pubmed/28683468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.215
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados